BRIEF-Ipsen and EpiVax collaborate to produce next generation botulinum toxins
October 26, 2015 at 14:31 PM EDT
* Announce together with the US company EpiVax, Inc. (EpiVax) that they have completed a collaborative project for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics Source text for Eikon: Further company coverage: (Gdynia Newsroom)
